VIMTA LABS
Back to All Ratios
|
VIMTA LABS Last 5 Year Payable days History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|
Payable days | - | - | 1,549.17 | - |
What is the latest Payable days ratio of VIMTA LABS ?
Year | Payable days |
---|---|
Mar2023 | - |
Mar2022 | - |
Mar2021 | 1,549.17 |
Mar2020 | - |
How is Payable days of VIMTA LABS Trending?
Years | Payable days | % Change | |
---|---|---|---|
Mar2023 | 0 | 0 | |
Mar2022 | 0 | -100.00 | |
Mar2021 | 1549.17 | 0 | |
Mar2020 | 0 | - |
Other Financial Ratios of VIMTA LABS
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Payable days ratio of peers of VIMTA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VIMTA LABS | ₹1,162.8 Cr | -3.4% | 15.3% | 38.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
VIMTA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VIMTA LABS | -3.4% |
15.3% |
38.9% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses